Global Lung Stent Market Poised to Witness Steady Growth due to Rising Prevalence of Lung Diseases
![]() |
Global Lung Stent Market |
The global lung stent market is a highly specialized one, with lung stents being medical devices inserted in the airways of lungs to relieve blockages. Lung stents find applications in treating conditions like lung cancer, COPD, and others that constrict airways. They help restore airflow and breathing by enlarging the air passageways. Compared to other alternatives like bronchoplasty, lung stenting is a minimally invasive procedure with advantages like faster recovery.
The
Global Lung Stent Market is estimated to be valued at US$ 206.5 million in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period of
2024 to 2031.
Key Takeaways
Key players operating in the global lung stent market are Boston Scientific,
Cook Medical, Medtronic, Taewoong Medical, Hospitech, Bess, Endo-Flex, Efer
Endoscopy, W. L. Gore & Associates, BD, Edwards Lifesciences, Healthy Medical
Corporation, Pulmonx Corporation, Meril Life Sciences Pvt. Ltd and C. R. Bard
Inc. Growing demand for minimally invasive procedures and technological
advancements in lung stents are fueling growth opportunities in the market.
North America dominates the global lung stent market currently. However, Asia
Pacific is expected to exhibit lucrative growth over the forecast period owing
to the rising lung disease prevalence, growing healthcare infrastructure, and
increasing focus on minimally invasive procedures in the region.
Market Drivers
The key driver contributing to the growth of the Global
Lung Stent Market Growth is the
rising prevalence of lung diseases worldwide. Conditions like lung cancer,
COPD, and emphysema are on the rise due to factors like rapid urbanization,
pollution, smoking, aging population etc. Lung stents help improve quality of
life of patients suffering from lung conditions by restoring air passageways.
Technological advancements leading to development of improved lung stenting
solutions is another major factor fueling the market growth. Growing preference
for minimally invasive procedures over complex open surgeries due to benefits like
less pain, scars and quicker recovery is boosting the adoption of lung stents
globally.
PEST Analysis
Political: The government policies related to healthcare expenditure and
reimbursement scenarios impact the market. Regulations related to new product
approval and import & export of medical devices influence the market.
Economic: Growing healthcare expenditure, rise in disposable income, and
availability of medical insurance/coverage are some key economic factors
driving the market.
Social: Increasing incidence of lung cancer and respiratory diseases, growing
aging population, and rising awareness about lung disease treatment options
support market growth.
Technological: Developments in lung stent technologies such as drug-eluting
stents, biodegradable stents, and self-expandable stents are helping expand
applications and driving the market. Advancements in material science
facilitate improvements in stent designs.
The North America region dominates the global lung stent market in terms of
value. The high healthcare expenditure, presence of major manufacturers and
research centers, and growing incidence of lung cancer and COPD contribute to
the region's large share.
The Asia Pacific region is projected to be the fastest growing market during
the forecast period. This is attributed to factors such as rising aging
population, growing healthcare expenditure, developing healthcare
infrastructure, and increasing incidence of lung cancer and respiratory
diseases in countries like China, India, and Japan.
Explore
More Articles - Commercial
Display Market
Comments
Post a Comment